Pune, India, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The global Non-invasive prenatal testing (NIPT) market size was USD 5.20 billion in 2022 and expected to grow USD 19.09 billion by 2030, exhibiting a CAGR of 17.8% during the forecast period. The increasing technological advancements to improve non-invasive prenatal testing (NIPT) capabilities will drive market growth during the forecast period.
Fortune Business Insights™ mentioned this in a report titled “Non-Invasive Prenatal Testing (NIPT) Market, 2023-2030.”
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/non-invasive-prenatal-testing-market-100998
Key Industry Development:
April 2021 – BioReference Laboratories, Inc., a subsidiary of OPKO Health, acquired the U.S. Ariosa centralized laboratory prenatal testing business from F. Hoffmann-La Roche Ltd to expand NIPT offerings.
Key Takeaways:
- The CDC reports that Down syndrome, also known as trisomy 21, is the most prevalent chromosomal anomaly, impacting approximately 1 in 700 infants born in the United States.
- Genetic Technologies Limited, an Australian company, revealed in July 2022 its expansion into the European and Indian markets through the acquisition of U.S.-based EasyDNA.
- Non-invasive tests have been established as the standard screening method for pregnant women in the Netherlands.
- In a recent news article from NBC News, it was reported that the average age of women in the United States who are giving birth has risen from 27 to 30.
Discover the Leading Players Featured in the Report:
Illumina, Inc. (U.S.), YOURGENE HEALTH (U.K.), Natera (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer Inc. (U.S.), Laboratory Corporation of America (U.S.), Eurofins LifeCodexx GmbH (Germany)
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2023 to 2030 |
| Forecast Period 2023 to 2030 CAGR | 17.8% |
| 2030 Value Projection | USD 19.09 billion |
| Base Year | 2022 |
| Market Size in 2023 | USD 6.07 billion |
| Historical Data | 2019-2021 |
| No. of Pages | 120 |
| Segments covered | By Product, Technology, End User, and Region |
Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998
Segmentation:
Increasing Number of Lab-Based Tests to Drive Segment Growth for Consumables & Reagents
By product, the market is segmented into consumables & reagents and instruments. The consumable & reagents segment will hold a major non-invasive prenatal testing (NIPT) market share during the forecast period. The growth is attributed to the increasing number of lab-based tests performed globally and the increasing launch of new test kits.
Rising Use of Next-Generation Sequencing (NGS) to Drive Market Growth
Based on technology, the market is classified into next-generation sequencing (NGS), microarray, polymerase chain reaction (PCR), and rolling circular amplification. The next-generation sequencing segment dominates the market due to the increasing use of next-generation sequencing (NGS) in different clinical applications to detect the risk of fetal chromosomal anomalies.
Growing Innovative Technological Advancements to Propel Segment Growth
By end-user, the market is divided into hospitals and clinical laboratories. The clinical laboratories segment dominated the market during the forecast period. The growing advancements in innovative technologies providing safe and effective prenatal tests for chromosomal abnormalities drive the segment’s growth in the non-invasive prenatal testing (NIPT) market.
Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
By Product
- Consumables & Reagents
- Instruments
By Technology
- Next Generation Sequencing (NGS)
- Microarray
- Polymerase Chain Reaction (PCR)
- Rolling Circular Amplification
By End User
- Hospitals
- Clinical Laboratories
By Region
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Driving factor:
Growing Product Innovations to Propel Market Growth
Several companies continuously focus on developing advanced technologies to detect genetic disorders in babies, boosting the non-invasive prenatal testing (NIPT) market during the forecast period. The companies are partnering to develop advanced non-invasive prenatal tests to strengthen their market positions. Many countries are adopting screening policies for detecting chromosomal abnormalities by including non-invasive prenatal screening tests.
The lack of adequate reimbursement policies for tests and lower per capita healthcare spending may hamper market growth during the forecast period.
Quick Buy – https://www.fortunebusinessinsights.com/checkout-page/100998
Regional insights:
Rising Penetration of NIPT to Drive Market Growth in North America
The North American market stood at USD 2.66 billion in 2022 and dominated in 2022. The growth is attributed to the rising penetration of non-invasive prenatal testing and the growing incidence of Down syndrome in newborns across North America.
Europe is estimated to experience significant growth during the projected period. The growing launch of new products by key players and the strong reimbursement framework of NIPT to boost market growth in the region.
Competitive Landscape
Growing Key Players Focus on Product Launches to Drive Market Growth
The increasing focus of key market players on launching new and innovative products and increasing adoption of robust research & development activities to strengthen their market position to drive market growth. The increasing adoption of new product offering strategies by major players will boost market growth during the forecast period.
FAQs
How big is the Non-Invasive Prenatal Testing Market?
Non-Invasive Prenatal Testing Market size is USD 6.07 billion in 2023.
How fast is the Non-Invasive Prenatal Testing Market growing?
The Non-Invasive Prenatal Testing Market will exhibit a CAGR of 17.8% during the forecast period, 2023-2030.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/non-invasive-prenatal-testing-market-100998
Related Links:
Next-Generation Sequencing (NGS) Market Size, Share, Growth Industry Report.
Molecular Diagnostics Market Share, Size, Demand, and Forecast.
In-Vitro Diagnostics (IVD) Market Size, Share, Growth Industry Report.
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Attachment
